Pricing Log in Create free account

Clene Inc. (CLNN) vs RenovoRx, Inc. (RNXT)

Clene Inc. and RenovoRx, Inc. are both Biotechnology companies. Clene Inc. and RenovoRx, Inc. are of similar size ($56.4M and $53.7M). RenovoRx, Inc. has the higher net margin (−469.0% vs −11,271.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, RenovoRx, Inc. leads on 10 and Clene Inc. on 4.

Valuation

Metric CLNN RNXT Biotechnology median
P/E n/m n/m 10.60
P/S 211.59 19.79 9.40
P/B n/m 5.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 196.34 17.77 9.02
Earnings yield (61.06%) (27.19%) (32.88%)
Free cash flow yield (33.01%) (22.25%) (23.13%)

Profitability

Metric CLNN RNXT Biotechnology median
Gross margin 68.49% 84.04% 68.51%
Operating margin (8,928.57%) (489.05%) 0.00%
Net margin (11,271.43%) (469.02%) 0.00%
Free cash flow margin (6,984.45%) (440.38%) 0.00%
Return on equity 197.50% (149.98%) (51.96%)
Return on assets (120.65%) (110.14%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN RNXT Biotechnology median
Revenue growth (TTM) 11.21% — 6.76%
EPS growth (last fiscal year) 53.26% 20.00% 29.88%
Revenue growth, 5-year CAGR (0.59%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN RNXT Biotechnology median
Debt to equity (0.42) 0.00 0.00
Current ratio 0.85 5.65 4.97
Net debt to EBITDA (0.39) 0.56 1.01

Dividend

Metric CLNN RNXT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLNN RNXT Biotechnology median
Market cap 56.43m 53.70m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack